Literature DB >> 20174771

What happens to patients who have their asthma device switched without their consent?

Scott Doyle1, Andrew Lloyd, Angela Williams, Henry Chrystyn, Mandy Moffat, Mike Thomas, David Price.   

Abstract

AIMS: To identify asthma patients who have experienced a non-consented switch (NCS) of their inhaler device and to explore the circumstances and impact of these switches.
METHODS: Nineteen asthma patients who had experienced an NCS of their inhaler device were recruited to participate in qualitative, semistructured one-to-one interviews.
RESULTS: All 19 participants reported a switch in their asthma inhaler without consultation or approval. There was deterioration in asthma control reported by some participants, many remained unchanged, and two reported better outcomes. Regardless of any change in asthma control, all patients expressed discontent with the NCS. Many felt it had damaged their relationship with their doctor, their confidence in their asthma medication, and their perception of control over their disease.
CONCLUSIONS: These qualitative interviews highlight the need to maintain clear and open communication with patients. Switching of patients' inhalers without their consent may diminish the self-control associated with good asthma management, leave the doctor-patient relationship damaged, increase resource utilisation, and waste medication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20174771      PMCID: PMC6602231          DOI: 10.4104/pcrj.2010.00009

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  17 in total

1.  Real-world asthma management with inhaler devices in Switzerland-results of the asthma survey.

Authors:  Christian F Clarenbach; Laurent P Nicod; Malcolm Kohler
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Pharmacy-led switches of 5-ASA: impact on secondary care.

Authors:  Chris J Healey; John O'Malley
Journal:  Frontline Gastroenterol       Date:  2012-11-12

3.  A Scoping Review of International Barriers to Asthma Medication Adherence Mapped to the Theoretical Domains Framework.

Authors:  Isaretta L Riley; Bryonna Jackson; Donna Crabtree; Shaun Riebl; Loretta G Que; Roy Pleasants; L Ebony Boulware
Journal:  J Allergy Clin Immunol Pract       Date:  2020-08-26

4.  Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey.

Authors:  Fulvio Braido; Ilaria Baiardini; Massimo Sumberesi; Francesco Blasi; Giorgio Walter Canonica
Journal:  Respir Res       Date:  2013-09-22

5.  Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues.

Authors:  Alessandro Roggeri; Claudio Micheletto; Daniela Paola Roggeri
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-21

6.  Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.

Authors:  Christer Janson; Thomas Lööf; Gunilla Telg; Georgios Stratelis; Folke Nilsson
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-17       Impact factor: 2.871

Review 7.  Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients.

Authors:  U S Björnsdóttir; S Gizurarson; U Sabale
Journal:  Int J Clin Pract       Date:  2013-06-16       Impact factor: 2.503

8.  Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients.

Authors:  David Price; Vicky Thomas; Julie von Ziegenweidt; Shuna Gould; Catherine Hutton; Christine King
Journal:  J Asthma Allergy       Date:  2014-04-10

9.  Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β₂ -agonists in obstructive lung diseases: a population-based, observational study.

Authors:  U S Björnsdóttir; S T Sigurðardóttir; J S Jonsson; M Jonsson; G Telg; M Thuresson; I Naya; S Gizurarson
Journal:  Int J Clin Pract       Date:  2014-07       Impact factor: 2.503

Review 10.  Switching treatments in COPD: implications for costs and treatment adherence.

Authors:  Fulvio Braido; Federico Lavorini; Francesco Blasi; Ilaria Baiardini; Giorgio Walter Canonica
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.